{
  "id": 9229680,
  "title": "New precision medicine venture gives Syngenis added firepower",
  "url": "https://urgent.news/2026/09/23/new-precision-medicine-venture-gives-syngenis-added-firepower-9229680",
  "topic": "world",
  "section": "World",
  "published": "2026-09-23T00:25:48.000Z",
  "source": {
    "name": "The Age",
    "slug": "the-age",
    "url": "https://www.theage.com.au/business/companies/new-precision-medicine-venture-gives-syngenis-added-firepower-20260923-p60zr2.html?ref=rss"
  },
  "original_language": "en",
  "account": null,
  "summary": "Syngenis has joined Perron Institute and Gene S founders in a new precision-medicine venture that puts its integrated DNA and RNA biotech platform to work.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Sydney Morning Herald",
        "title": "New precision medicine venture gives Syngenis added firepower",
        "url": "https://urgent.news/2026/09/23/new-precision-medicine-venture-gives-syngenis-added-firepower",
        "published": "2026-09-23T00:25:48.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}